Trials / Completed
CompletedNCT07150507
The Effectiveness of Breathing Therapy in Patients With Schizophrenia
Effectiveness of Breathing Therapy in Reducing Sleep and Fatigue Symptoms in Patients With Schizophrenia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Ataturk University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study aimed to determine the effects of breathing therapies on sleep disturbances and fatigue in patients with schizophrenia.The study will be conducted at a CMHC in Ağrı province between May and August 2021. At the CMHC, community-based mental health services are provided to patients with severe mental disorders (schizophrenia, bipolar disorder) who are in remission as assessed by a psychiatrist. The study is planned to be conducted with patients who meet the study criteria, without using a sample selection method. Patients over the age of 18 registered with CMHC and followed with a diagnosis of schizophrenia were contacted by phone and invited to CMHC. The study was conducted with patients who met the inclusion criteria and agreed to participate. Data will be collected using the Descriptive Characteristics Form, the DSM-5 Sleep Disorder Scale, and the Brief Fatigue Inventory. The experimental group received eight sessions of respiratory therapy.The control group received no intervention. The study sample size was calculated using the GPower computer program. A power analysis performed at α=0.05 revealed an effect size of 150.153 (d=0.8), providing 90% power. Therefore, it was calculated that a minimum of 68 patients should be included in the sample.
Detailed description
Study data were collected by the researcher through face-to-face interviews. The study included individuals diagnosed with schizophrenia who met the inclusion criteria (registration in a CMHC, having a diagnosis of schizophrenia, willingness to participate in the study, and openness to communication and collaboration). Pre-test measurement instruments were administered to the participants. The experimental group received eight sessions of respiratory therapy. The control group received no intervention. Post-test data were collected following the training sessions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Session 1: Preparation Session | \*Meeting Patients \*Introducing the Content of Psychoeducation \*Emphasizing the Importance of Regular and Timely Attendance at Training \*Determining Training Dates \*Sharing Individuals' Experiences and Expectations |
| OTHER | Session 2: Recognizing the Illness | \*What is Schizophrenia? \*What are its Symptoms? \*What Does Treatment Include? |
| OTHER | Session 3: Treatment Evaluation | \*Things to Consider When Using Medication \*Side Effects of Medication \*Exacerbation of Schizophrenia \*Precursor Symptoms. |
| OTHER | Session 4: What is anger? | \*What are the symptoms of anger? \*What are the methods for coping with anger? |
| OTHER | Session 5: Communication | \*What is communication? \*The importance of communication. \*Fundamentals of communication, working on "I" language. \*Ways to prevent communication difficulties. |
| OTHER | Session 6: What is relaxation? | What is progressive relaxation? Introducing a relaxation CD |
| OTHER | Session 7: Relaxation | Practicing the relaxation CD with patients |
| OTHER | Session 8: Evaluation | \*Reinforcing what has been learned. \*Evaluating the program. \*Obtaining feedback |
Timeline
- Start date
- 2022-04-29
- Primary completion
- 2022-11-15
- Completion
- 2023-05-15
- First posted
- 2025-09-02
- Last updated
- 2025-09-02
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07150507. Inclusion in this directory is not an endorsement.